Prurigo Nodularis clinical trials at UCSF

• A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Prurigo Nodularis

  Sorry, in progress, not accepting new patients

  Study of the efficacy, safety, tolerability, pharmacokinetics (PK) and immunogenicity of KPL-716 in subjects with prurigo nodularis.

  San Francisco, California and other locations

Last updated: April 23, 2020